Emcure Pharmaceuticals has announced the re-appointment of three independent directors for second terms, following approval from the company’s members through a postal ballot and remote e-voting process. The re-appointments include Mr. Vijay Keshav Gokhale, Dr. Vidya Rajiv Yeravdekar, and Dr. Shailesh Kripalu Ayyangar.
Mr. Vijay Keshav Gokhale will serve a second term of five consecutive years starting from 16 April 2026. Dr. Vidya Rajiv Yeravdekar has been re-appointed for a second term of three consecutive years, also beginning on 16 April 2026. Dr. Shailesh Kripalu Ayyangar will continue for another five-year term, effective from 2 June 2026.
The company confirmed that all three directors are not debarred from holding office by any Securities and Exchange Board of India (SEBI) order or any other authority. Additionally, they are not related to any directors or key managerial personnel of Emcure Pharmaceuticals.
The remote e-voting process concluded at 5:00 p.m. IST on 20 March 2026, and the results of the postal ballot were announced on 24 March 2026, following the receipt of the scrutiniser’s report dated 23 March 2026.
Disclaimer: This article is based on a regulatory filing submitted to the National Stock Exchange of India (NSE).